Cardiac Cryoablation System

Related by string. * CARDIAC . Cardiacs . cardiac : suffered cardiac arrest . sudden cardiac arrest . sudden cardiac death . cardiac rhythm / cryoablation : CryoCor Cardiac Cryoablation System . percutaneous cryoablation . Front Cardiac CryoAblation . proprietary cryoablation / SYSTEM . SYSTEMS . system : Systems Network FEWS . Blue Coat Systems . Global Positioning System * *

Related by context. Frequent words. (Click for all words.) 61 Icatibant 59 PFO closure 58 symptomatic uterine fibroids 58 hypoparathyroidism 58 ecallantide 58 Levulan PDT 57 Investigational Device Exemption 57 CORTOSS 57 lupus nephritis 57 ATryn R 57 CE Marked 57 alvimopan 57 ATryn ® 56 received CE Marking 56 Orphan Drug Status 56 arterial thrombosis 56 Pivotal Trial 56 REMICADE ® 56 Increlex 56 vertebral compression fractures 56 FavId 56 Omigard 56 pseudobulbar affect PBA 55 Loramyc ® 55 Zelrix 55 diabetic neuropathic pain 55 NEBIDO 55 secondary hyperparathyroidism 55 BLA submission 55 Orphan Drug status 55 refractory epilepsy 55 MONOVISC 55 Iluvien 55 Pirfenidone 55 confirmatory Phase III 55 Orphan Drug designation 55 orphan designation 54 relapsed refractory multiple myeloma 54 PREOS 54 MOZOBIL 54 Investigational Device Exemption IDE 54 Phenoptin 54 acute decompensated heart 54 diabetic peripheral neuropathy 54 calcineurin inhibitors 54 Alemtuzumab 54 orphan medicinal product 54 registrational 54 Ventavis 54 diabetic macular edema 54 Marketing Authorization Application 54 squalamine 54 romiplostim 54 Cethrin 54 pharmacologic stress agent 54 methylnaltrexone 54 Fast Track designation 54 Pivotal Phase III 54 refractory Hodgkin lymphoma 53 pulmonary arterial hypertension 53 GEM #S 53 biologic therapy 53 Cimzia R 53 chronic angina 53 oncology indications 53 Stedivaze 53 investigational 53 TORISEL 53 SinuNase 53 silodosin 53 voclosporin 53 diabetic macular edema DME 53 pancreatic insufficiency 53 Fast Track Designation 53 carcinoid syndrome 53 malignant pleural mesothelioma 53 Topical Interferon Alpha 2b 53 Coronary Stent System 53 Allovectin 7 R 53 Phase IIa clinical trials 53 non alcoholic steatohepatitis 53 Phase 2b clinical 52 autoimmune indications 52 intravenous formulation 52 metastatic liver 52 Amrubicin 52 Destination Therapy 52 SHPT 52 photodynamic therapy PDT 52 pulmonary arterial hypertension PAH 52 NUEDEXTA 52 alogliptin 52 clofarabine 52 hereditary angioedema 52 Phase IIa trial 52 6R BH4 52 therapeutic modalities 52 Zerenex 52 Mozobil 52 allogeneic stem cell 52 Clolar

Back to home page